Fact-checked by Grok 2 weeks ago

Panic disorder

Panic disorder is an characterized by recurrent and unexpected episodes of intense fear or discomfort, known as panic attacks, that peak within minutes and are accompanied by physical and cognitive symptoms such as heart palpitations, sweating, trembling, , , , , or hot flashes, feelings of unreality, fear of losing control or dying, and a . At least four of these symptoms must occur during an attack to meet diagnostic criteria, and the disorder is distinguished by persistent worry about additional attacks or their consequences, leading to significant behavioral changes. Panic disorder often begins in late or early adulthood, with a lifetime of approximately 2.7% to 4.7% in the general population, and it affects women more frequently than men, with past-year prevalence rates of 3.8% among females compared to 1.6% among males . The exact causes of panic disorder remain unclear, but research indicates a combination of genetic, biological, and environmental factors. Genetic predisposition plays a role, with first-degree relatives of affected individuals having up to a 40% risk of developing the disorder, and specific gene variants related to neurotransmitter systems like serotonin and GABA have been implicated. Major life stressors, such as trauma, loss, or significant changes, can trigger onset, particularly in those with a sensitive temperament or history of childhood abuse. Additionally, changes in brain function, including overactivity in the amygdala and dysregulation of the body's fight-or-flight response, contribute to the hypersensitivity seen in panic disorder. Risk factors include family history of panic disorder, excessive caffeine or substance use, smoking, and co-occurring conditions like depression or other anxiety disorders. If untreated, panic disorder can lead to complications such as (avoidance of situations where escape might be difficult), , , substance misuse, and impaired functioning in work or relationships. typically involves a clinical based on criteria, ruling out medical conditions like cardiac issues or that may mimic symptoms. Effective treatments include (), which helps individuals identify and modify thought patterns and behaviors related to panic, and pharmacotherapy with selective serotonin reuptake inhibitors (SSRIs) like sertraline or as first-line options, often combined with short-term benzodiazepines for acute relief. With appropriate intervention, most people experience significant symptom reduction, though maintenance treatment may be needed for 6-12 months or longer to prevent relapse.

Signs and symptoms

Panic attacks

A panic attack is defined as an abrupt surge of intense fear or intense discomfort that reaches a peak within minutes, and during which time four or more of a specific set of physical and cognitive symptoms occur. According to the , these symptoms include , pounding heart, or accelerated heart rate; sweating; trembling or shaking; sensations of or smothering; feelings of ; or discomfort; or abdominal distress; feeling dizzy, unsteady, light-headed, or faint; or heat sensations; paresthesias (numbness or tingling sensations); (feelings of unreality) or depersonalization (being detached from oneself); fear of losing control or "going crazy"; and fear of dying. The physical symptoms of a panic attack often mimic life-threatening conditions, leading individuals to seek medical care. Common manifestations include cardiovascular symptoms such as rapid heartbeat or , which can feel like a heart attack, and respiratory symptoms like or sensations of suffocation. Other physical signs encompass gastrointestinal distress, such as , and autonomic responses like sweating, trembling, , chills, or hot flushes. Cognitive symptoms during a typically involve overwhelming dread and distorted perceptions. Individuals may experience intense fear of dying, , or losing control, often accompanied by —where surroundings feel unreal—or depersonalization, a sense of detachment from one's body or thoughts. attacks generally last 5 to 20 minutes, though they can vary in duration and may feel longer to the affected person due to the intensity of symptoms. They are classified as expected if triggered by a specific cue or situation, such as phobic , or unexpected if occurring spontaneously without an identifiable trigger. Symptom clusters in panic attacks often group into distinct patterns, such as a cardiovascular cluster featuring and that simulates a cardiac event, or a respiratory cluster involving dyspnea and that heightens suffocation fears. These clusters highlight how interoceptive cues, like bodily sensations of , can escalate the attack.

Persistent worry and behavioral changes

Individuals with panic disorder experience persistent concern or worry about the occurrence of additional panic attacks or their potential consequences, such as losing control, suffering a heart attack, or "going crazy," with this apprehension lasting for at least one month. This anticipatory anxiety distinguishes panic disorder from isolated panic attacks and often manifests as a constant undercurrent of dread, where individuals ruminate on the possibility of future episodes even in the absence of immediate triggers. The fear typically arises from the memory of acute physical symptoms during prior attacks, such as or , leading to a heightened state of vigilance. In response to this ongoing worry, individuals often develop significant maladaptive behavioral changes aimed at preventing or mitigating perceived risks of panic attacks. Common avoidance behaviors include steering clear of situations believed to trigger attacks, such as crowded places, driving, or being alone, which serve as short-term relief but perpetuate the cycle of anxiety. For instance, may alter their travel habits by restricting outings to familiar routes or relying on companions for reassurance, thereby limiting spontaneous activities and fostering dependence on others. These behavioral adaptations profoundly impact daily functioning, interfering with occupational performance, social interactions, and routine tasks, as individuals prioritize safety over normal engagement with life. In severe cases, avoidance escalates to , where of being unable to escape or obtain help in public settings confines individuals to their homes or safe zones, exacerbating isolation. The emotional toll includes sustained heightened anxiety and to bodily sensations, where minor physical cues like a racing heart are interpreted as harbingers of impending attacks, contributing to . This prolonged strain frequently leads to secondary , with comorbid depressive symptoms arising from the cumulative burden of restricted living and unremitting .

Causes and risk factors

Genetic and biological factors

Twin and family studies, including meta-analyses of high-quality data, estimate the of panic disorder to be between 30% and 50%, indicating a substantial genetic contribution to its . Recent genome-wide association studies (GWAS) have identified multiple genetic loci associated with panic disorder and broader anxiety disorders. For instance, a 2024 meta-analysis of over 122,000 European-ancestry cases pinpointed 58 loci, highlighting signaling pathways as key biological mechanisms underlying susceptibility. Some genetic variants have shown associations with panic disorder in candidate gene studies, such as polymorphisms in the COMT gene (involved in catecholamine regulation) and limited evidence for the serotonin transporter gene SLC6A4, though results for the latter are mixed and not consistently replicated across populations. Similarly, polymorphisms in genes encoding receptors, including the GABRA6 subunit, have been implicated in altered inhibitory that may heighten vulnerability to panic symptoms. Dysregulation of the hypothalamic-pituitary-adrenal () axis represents a key biological marker in panic disorder, with patients demonstrating elevated baseline levels and heightened HPA responsiveness to stress challenges. This hyperactivity persists even during non-panic states, suggesting an underlying physiological vulnerability that amplifies stress responses and contributes to disorder onset. Neuroendocrine factors, such as cholecystokinin (CCK), further contribute to panic susceptibility, as demonstrated in animal models where CCK administration elicits panic-like behaviors through activation of CCK receptors in anxiety-related pathways. Sex differences in prevalence, with women affected at roughly twice the rate of men, may involve estrogen's modulation of circuits, enhancing sensitivity to signals in female physiology. Additionally, early-life temperamental traits like behavioral inhibition, characterized by heightened caution toward novelty, serve as a heritable , observable in offspring of affected parents and predictive of later panic disorder development.

Psychological and environmental factors

Psychological models of panic disorder emphasize learned processes that contribute to the development and maintenance of the condition. According to Clark's , panic attacks arise from the catastrophic misinterpretation of benign bodily sensations, such as heart palpitations or , as signs of imminent danger, leading to a vicious cycle of escalating anxiety and further physical symptoms. also plays a role, wherein neutral cues, including internal bodily signals, become associated with through repeated pairing with initial anxiety-provoking experiences, thereby triggering subsequent responses. Environmental stressors frequently precede and exacerbate panic disorder. Major life events, such as bereavement, trauma, or significant role transitions, often occur in the year leading up to the first , with studies indicating heightened frequency of such events in affected individuals compared to controls. Chronic stress further amplifies vulnerability by heightening and disrupting emotional regulation, thereby increasing the likelihood of panic onset in predisposed individuals. Substance use and withdrawal represent key environmental risks for precipitating panic attacks. Consumption of , equivalent to about five cups of , can induce in a substantial proportion of those with panic disorder by mimicking and intensifying symptoms. from elevates the risk of panic disorder onset, with regular smokers facing approximately 2 to 3 times higher odds compared to non-smokers. Withdrawal from or sedatives similarly triggers through rebound anxiety and heightened autonomic . Stimulants like can precipitate acute attacks by overstimulating the and mimicking catastrophic bodily sensations. Childhood adversity contributes to long-term risk through developmental pathways. Parental overprotection fosters dependency and fear of , which has been linked to the emergence of anxiety disorders, including , in adulthood. Early experiences of separation anxiety or actual separations during childhood also heighten susceptibility, potentially serving as precursors to later symptoms. Cultural and situational environmental factors influence incidence rates. Urban living correlates with higher prevalence of anxiety disorders, including , due to increased to , crowding, and social stressors that elevate overall levels. Similarly, high-stress occupations, such as those involving or high responsibility, are associated with greater psychological distress and a 20% increased odds of anxiety-related conditions compared to low-risk jobs.

Pathophysiology

Neurobiological mechanisms

Panic disorder involves dysregulation in several key brain regions implicated in fear processing and emotional regulation. The exhibits hyperactivity, serving as a central hub for detecting and responding to potential threats, which contributes to the rapid onset of panic attacks. The insula shows increased activation related to heightened interoceptive awareness of bodily sensations, amplifying perceived danger signals. Dysfunction in the , particularly reduced activity in the , impairs top-down regulation of fear responses, leading to unchecked emotional escalation. Additional circuits include the (PAG), which mediates circa-strike defense behaviors and autonomic arousal in response to internal threats such as suffocation, and the bed nucleus of the stria terminalis (BNST), involved in sustained threat monitoring and associated with . Subsets of neurons in the (DRN) further distinguish between sustained anxiety and acute panic responses. Neurotransmitter imbalances play a critical role in the disorder's . Overactivity in the noradrenergic system, originating from the , heightens arousal and vigilance, promoting exaggerated stress responses during episodes. Serotonin deficiency disrupts mood stabilization and , while deficits in inhibition fail to dampen excessive neural firing in fear circuits. Dysfunction in the endogenous system lowers the , with impaired serotonin-opioid interactions in the dorsal PAG contributing to onset, as evidenced by studies like naloxone-lactate . These alterations collectively lower the for induction. The is heavily involved, with surges during attacks triggering the classic , including , , and sweating. This physiological cascade reinforces the subjective experience of . Recent functional MRI (fMRI) studies have revealed altered connectivity within fear networks, such as decreased coupling between the and prefrontal regions, which correlates with panic severity and anticipatory anxiety. Emerging research also highlights the modulatory role of endocannabinoids, where enhanced endocannabinoid signaling in the can attenuate panic-like responses by fine-tuning processing. A 2024 study identified a novel pathway in mice involving PACAP (pituitary adenylate cyclase-activating polypeptide)-expressing neurons in the lateral parabrachial nucleus (PBL) projecting to DRN neurons, mediating panic symptoms independently of the ; inhibiting this signaling reduced panic-like behaviors. Animal models provide mechanistic insights, particularly through CO2 inhalation paradigms in , which induce panic-like behaviors via detected by (ASICs) in the . Blocking ASIC1a reduces these fear responses, underscoring a conserved pathway for CO2 in panic disorder.

Role of

refers to the perception and integration of internal bodily signals from visceral organs, such as , , and gastrointestinal sensations, which provide a continuous representation of the body's internal state. In the context of panic disorder, heightened interoceptive sensitivity amplifies awareness of these signals, often through the trait of , where individuals exhibit an exaggerated fear of benign bodily sensations due to beliefs that they signal imminent harm. This sensitivity contributes to panic attacks via a mechanism involving catastrophic misinterpretation of normal physiological changes, such as perceiving a slight increase in as a heart attack, which triggers autonomic and perpetuates a vicious loop of escalating anxiety and symptoms. Interoceptive conditioning, where neutral bodily cues become associated with fear through repeated pairings, further entrenches this process, transforming innocuous signals into potent triggers for . Empirical evidence supports elevated interoceptive accuracy among individuals with panic disorder, particularly in heartbeat detection tasks, where patients outperform controls in perceiving cardiac signals under resting conditions, suggesting a predisposition to hypervigilance for bodily cues. Seminal studies, such as those using the heartbeat counting paradigm, have demonstrated this enhanced accuracy in panic patients compared to non-anxious groups, linking it to the disorder's onset and maintenance. Interoception in panic disorder encompasses distinct subtypes, including cardiac interoception, which involves precise detection of heart-related signals and is often heightened, and respiratory interoception, which focuses on breath sensations and shows variable associations with anxiety but contributes to dyspnea interpretations during attacks. Nocturnal panic, occurring during sleep transitions, is particularly tied to altered of sleep-related interoceptive signals, such as subtle respiratory changes or reduced vigilance, leading to abrupt awakenings with intense fear. Recent advancements as of 2025 include (VR) paradigms for assessing and manipulating , enabling controlled simulation of bodily sensations to probe panic mechanisms and test interventions in immersive environments, with preliminary neurophysiological data showing enhanced responses in patients.

Diagnosis

Diagnostic criteria

The diagnosis of panic disorder relies on standardized criteria outlined in major classification systems, ensuring consistent identification across clinical settings. According to the , panic disorder is characterized by recurrent unexpected panic attacks, defined as an abrupt surge of intense fear or intense discomfort that reaches a peak within minutes, accompanied by four or more of the following symptoms: palpitations, pounding heart, or accelerated ; sweating; trembling or shaking; sensations of or smothering; feelings of choking; or discomfort; or abdominal distress; feeling dizzy, unsteady, light-headed, or faint; chills or heat sensations; paresthesias (numbness or tingling sensations); (feelings of unreality) or depersonalization (being detached from oneself); fear of losing control or "going crazy"; or fear of dying. At least one of these attacks must be followed by one month or more of persistent concern or worry about additional panic attacks or their consequences (e.g., losing control, having a heart attack, "going crazy"), or a significant maladaptive change in behavior related to the attacks (e.g., avoidance of exercise or unfamiliar situations). The disturbance cannot be attributable to the physiological effects of a substance (e.g., abuse or medication) or another medical condition (e.g., , cardiopulmonary disorders), and it is not better explained by another . The aligns closely with the , defining panic disorder as recurrent unexpected panic attacks not restricted to particular stimuli or situations, where each attack involves an abrupt onset of intense fear or discomfort peaking within minutes and including at least four of the same core symptoms as in , such as , sweating, trembling, , , , , chills, paresthesias, or depersonalization, fear of losing control, or fear of dying. These attacks must be accompanied by either persistent worry about further attacks or their consequences, or significant behavioral changes related to the attacks, lasting at least several weeks, and the symptoms must not be better explained by another health condition, substance effects, or . Clinical diagnosis typically involves a to assess the history of , including their onset, frequency, duration, and associated symptoms, while excluding triggers linked to other conditions such as specific phobias or social situations. To quantify severity and monitor progress, tools like the Panic Disorder Severity Scale (PDSS) are employed; this 7-item clinician-administered scale evaluates aspects such as frequency, distress during attacks, anticipatory anxiety, agoraphobic avoidance, and overall sense of control, with total scores ranging from 0 to 28, where higher scores indicate greater severity. As of 2025, diagnostic criteria in both DSM-5-TR and incorporate flexibility for cultural variations in symptom presentation, such as , neck soreness, , or uncontrollable screaming in certain non-Western contexts, which do not count toward the required four symptoms but inform the overall clinical picture to avoid misdiagnosis.

Differential diagnosis

The of panic disorder involves distinguishing its recurrent, unexpected panic attacks accompanied by persistent concern or behavioral changes from other conditions that produce similar acute and psychological symptoms. Clinicians must systematically rule out medical and psychiatric mimics to ensure accurate , as misattribution can delay appropriate care. Medical conditions often mimic panic disorder due to overlapping symptoms such as , dyspnea, , , and sweating. Cardiac arrhythmias, including , can present with sudden and syncope, necessitating electrocardiogram (ECG) evaluation and possibly Holter monitoring to exclude arrhythmias. may cause , tremors, and anxiety-like agitation, warranting like TSH and free T4 levels. Asthma exacerbations mimic dyspnea and chest tightness, requiring pulmonary function tests or peak flow measurements. Vestibular disorders, such as , produce and imbalance that resemble panic-related , typically assessed via Dix-Hallpike maneuver or electronystagmography. A comprehensive workup, including ECG, , , thyroid studies, and chest if indicated, is recommended to exclude these organic causes before confirming a psychiatric . Psychiatric differentials include other s where panic-like episodes occur but lack the recurrent, unexpected nature central to panic disorder. (PTSD) features panic attacks cued by trauma reminders, distinguished by the presence of re-experiencing, avoidance, and hyperarousal symptoms. involves fear of scrutiny in social situations, with physiological arousal more predictable and context-specific than in panic disorder. Substance-induced anxiety disorder arises from intoxication or withdrawal (e.g., , , or ), identified through history of substance use temporally linked to symptoms; or collateral reports aid differentiation. Somatic symptom disorder presents with prominent physical complaints without clear medical explanation, but lacks the intense fear of impending doom typical of panic attacks. Nocturnal panic attacks, occurring during in up to 70% of panic disorder cases, must be differentiated from night terrors. Nocturnal panic involves abrupt awakening with full awareness of intense fear, heart racing, , and subsequent recall of the episode, often leading to sleep avoidance. In contrast, night terrors arise from non-REM sleep with partial arousal, manifesting as screaming, thrashing, or autonomic arousal without coherent recall or orienting to surroundings upon intervention; they are more prevalent in children but can occur in adults. may be used if sleep architecture abnormalities are suspected. When panic disorder co-occurs with depression or obsessive-compulsive disorder (OCD), both conditions are diagnosed if independent criteria are met, with prioritization based on symptom onset, severity, and functional impact to guide initial intervention. For instance, in comorbid , persistent low mood and predominate, but panic attacks may exacerbate avoidance; the primary diagnosis is the one better explaining the overall presentation. Similarly, in OCD with panic features, intrusive obsessions and compulsions take precedence if they drive the anxiety, as opposed to uncued panic. Diagnostic overlap requires careful assessment to avoid underdiagnosing the core disorder. As of 2025, heightened awareness has emerged regarding as a potential trigger for panic-like symptoms, including , dyspnea, and anxiety, which can mimic or precipitate panic disorder. These post-viral manifestations, persisting beyond , often involve autonomic dysregulation and require exclusion via history of recent infection and targeted testing, such as inflammatory markers or autonomic function assessments.

Treatment

Psychotherapy

Psychotherapy, particularly evidence-based talk therapies, serves as a first-line for panic disorder, emphasizing skill-building to address maladaptive thoughts and behaviors associated with panic attacks. Among these, (CBT) is the most widely recommended and researched approach, with meta-analyses indicating moderate to large effect sizes and response rates around 40-60% in reducing panic frequency and severity. CBT targets the of panic, where misinterpretation of benign bodily sensations as catastrophic leads to escalating anxiety, by teaching patients to identify and challenge these distortions. Core components of CBT include , which involves examining and reframing catastrophic thoughts—such as interpreting heart palpitations as a heart attack—through evidence-based questioning and alternative explanations, thereby reducing anticipatory anxiety. Another key element is , where individuals gradually confront feared situations or sensations to habituate and disprove feared outcomes, often starting with imaginal exercises and progressing to in vivo exposures like entering crowded spaces. These techniques, delivered over typically 12-16 sessions, empower patients to regain control and prevent avoidance behaviors that perpetuate the disorder. A specialized form of within is , which focuses on deliberately inducing panic-like physical sensations to desensitize fear responses and build tolerance. Common exercises include rapid spinning to mimic , to simulate , or running in place to evoke rapid , repeated until anxiety subsides, which has been validated as an effective component in reducing symptom . This approach directly counters the heightened interoceptive central to panic disorder. Other psychotherapeutic modalities offer complementary options for those who may not fully respond to standard CBT. Acceptance and commitment therapy (ACT), a mindfulness-based extension of CBT principles, promotes acceptance of panic sensations without struggle, using techniques like defusion from anxious thoughts and values-guided action to enhance psychological flexibility and reduce avoidance. Studies indicate ACT's efficacy in decreasing panic symptoms by fostering a nonjudgmental stance toward internal experiences. Similarly, panic-focused psychodynamic psychotherapy (PFPP) explores unconscious conflicts and relational patterns contributing to panic, with randomized trials showing it achieves comparable remission rates to CBT, particularly in reducing functional impairment and dropout. CBT and related therapies can be delivered in various formats to improve accessibility, including individual sessions for personalized tailoring, group settings to normalize experiences and provide , or online platforms for remote delivery. Recent evidence from 2025 meta-analyses supports digital applications, such as app-based programs with guided modules, demonstrating efficacy equivalent to in-person therapy in symptom reduction for panic disorder. Guidelines recommend combining with pharmacological treatments for optimal outcomes in many cases.

Pharmacological interventions

Pharmacological interventions for panic disorder primarily target the neurochemical imbalances implicated in anxiety responses, with selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine inhibitors (SNRIs) serving as first-line treatments due to their favorable , safety profile, and long-term tolerability. SSRIs such as sertraline and , and SNRIs like , are recommended for their ability to reduce frequency and severity by enhancing serotonin and norepinephrine availability in the . These medications typically require 4-6 weeks to achieve full therapeutic effects, with response rates ranging from 50-70% in clinical trials, though initial dosing should start low (e.g., sertraline at 25 mg/day) to minimize the risk of transient symptom exacerbation. Common side effects include , , and , which often diminish over time, but monitoring for or in the early weeks is essential. For acute relief during severe panic episodes, benzodiazepines such as are employed short-term, providing rapid effects within minutes by enhancing neurotransmission. However, their use is limited to 2-4 weeks due to high risks of , , and withdrawal symptoms, including rebound anxiety; guidelines advise against long-term monotherapy. Dosing typically involves low intermittent amounts (e.g., 0.25-0.5 mg as needed), with careful tapering to prevent discontinuation syndrome. Alternative options include beta-blockers like for managing somatic symptoms such as and tremors, particularly in performance anxiety contexts, though they do not address core cognitive aspects of panic. Tricyclic antidepressants (TCAs), such as , offer efficacy comparable to SSRIs in reducing panic frequency but are second-line due to side effects like dry mouth and , and cardiac risks requiring ECG . Overall treatment involves regular assessment of symptom remission using scales like the Panic Disorder Severity Scale, with dose adjustments every 2-4 weeks and consideration of drug interactions, especially in . Preliminary evidence as of 2025 suggests may show promise for treatment-resistant anxiety disorders, including potential applications in panic disorder, with systematic reviews indicating positive outcomes in refractory cases, though is primarily approved for and requires further research for anxiety-specific use in supervised settings.

Lifestyle and self-management strategies

Lifestyle and self-management strategies play a crucial role in managing panic disorder by helping individuals reduce the frequency and intensity of panic attacks through daily habits that promote physiological and . These approaches, often used alongside professional treatment, focus on modifiable behaviors that address triggers and build coping skills. Evidence from clinical studies supports their efficacy in lowering overall anxiety levels and improving . Regular , such as brisk walking, jogging, or cycling for at least 30 minutes most days of the week, has been shown to decrease anxiety symptoms in people with panic disorder by promoting endorphin release and modulating the body's response. In one study, participants with panic disorder who engaged in 30 minutes of at 70% of maximum oxygen uptake were significantly less likely to experience a during subsequent challenges compared to non-exercisers. Meta-analyses indicate that consistent can reduce anxiety symptoms by a moderate , equivalent to approximately 20-30% improvement in symptom severity for many individuals. Relaxation techniques, including (PMR) and deep breathing exercises, are effective self-management tools to interrupt the physiological escalation of panic, such as and muscle tension. PMR involves systematically tensing and releasing muscle groups to foster a sense of bodily control, while —inhaling deeply through the nose for 4 counts, holding for 4, and exhaling for 4—activates the to counteract the . Evidence suggests these techniques can help reduce anxiety symptoms when practiced regularly. Dietary adjustments, particularly limiting and intake, can mitigate triggers by avoiding substances that exacerbate arousal. has been linked to increased risk of attacks in susceptible individuals, and avoiding it is recommended to reduce this risk. Similarly, reducing consumption helps prevent rebound anxiety and disruptions that may precipitate nocturnal . Sleep hygiene practices are essential for addressing nocturnal attacks, which affect up to 70% of individuals with and often stem from fragmented or hyperarousal. Establishing a consistent routine—such as maintaining fixed bed and wake times, creating a cool and dark environment, and avoiding screens an hour before bed—improves quality and reduces the likelihood of nighttime awakenings in . Research shows that poor correlates with higher frequency, while targeted improvements can decrease nocturnal episodes by enhancing overall restorative . Support resources like diaries, groups, and mobile apps empower individuals to track patterns and build community. Keeping a daily of triggers, symptoms, and responses facilitates early and insight into personal patterns, with studies indicating improved and reduced attack recurrence. groups provide validation and shared strategies, while apps such as MindShift offer guided breathing exercises, symptom trackers, and educational content tailored to anxiety management. These tools, when used regularly, enhance adherence to self-management and complement therapeutic progress.

Prognosis and complications

Long-term outcomes

Panic disorder often follows a fluctuating course, with many individuals experiencing periods of remission interspersed with recurrences, though outcomes vary based on adherence and individual factors. Longitudinal studies indicate remission rates of approximately 30-50% for full among those receiving appropriate interventions, while untreated cases show higher chronicity in 20-40% of individuals over extended periods. For instance, a 5-year prospective follow-up found a 39% probability of remission for panic disorder, with or without . An 11-year study reported a good chance of from panic attacks and associated disabilities, including full remission in a substantial subset. Relapse risks are notably elevated following discontinuation of pharmacological treatments, reaching up to 50% in some cohorts, and cumulative rates can range from 50% to 89% over 3-8 years in treatment-as-usual scenarios. Protective factors against relapse include early and integrated approaches, which have been associated with relapse rates as low as 14% over mean survival times of 65 months. Post-remission, individuals often report improved , with reduced functional impairments in daily activities and social functioning; however, residual avoidance behaviors persist in some cases, contributing to ongoing limitations. Panic disorder is linked to poorer health-related even after symptom reduction, particularly when avoidance patterns endure. Prognostic indicators favoring better long-term outcomes include a shorter duration of symptoms at onset and the absence of , which predicts higher remission rates—around 70% at 2 years for panic disorder without compared to lower rates when is present. Recent 2025 longitudinal data from studies on concentrated treatments, such as the 4-day program, demonstrate significant symptom reductions (effect size d=5.03) maintained over longer-term follow-ups, aligning with remission rates of approximately 70% at 2 years for panic disorder without in broader research.

Comorbid conditions

Panic disorder frequently co-occurs with other psychiatric conditions, amplifying symptom severity and functional impairment. Lifetime comorbidity with affects approximately 50-55% of individuals with panic disorder, contributing to greater persistence of symptoms and reduced treatment response. Comorbidity with other anxiety disorders is also prevalent, reaching up to 80% overall, with specifically co-occurring in about 30% of cases, often leading to overlapping worry patterns and heightened autonomic arousal. Substance use disorders, including and dependence, are reported in 20-30% of patients, frequently as a maladaptive mechanism for panic symptoms that exacerbates overall morbidity. Agoraphobia develops in 25-50% of panic disorder cases, typically following repeated panic attacks and resulting in avoidance behaviors that promote and dependency. This intensifies the disorder's impact, limiting daily activities and increasing the likelihood of secondary complications like or relationship strain. Somatic comorbidities further compound risks; from panic disorder elevates the incidence of cardiovascular diseases, such as , by promoting sustained sympathetic activation and inflammation. Suicide risk is markedly heightened in panic disorder, with odds ratios indicating a 3- to 10-fold increase compared to the general population, particularly when comorbid with or substance use. Recent 2025 has identified emerging links between anxiety disorders and autoimmune conditions, suggesting bidirectional associations where anxiety may trigger immune dysregulation, increasing susceptibility to disorders like by up to 1.28 times (with potential relevance to panic disorder). Similarly, studies on post-viral syndromes, including , highlight panic-like symptoms that may persist, potentially due to neuroinflammatory effects that mimic or precipitate full panic disorder. These connections underscore the need for integrated screening in affected populations.

Epidemiology

Prevalence and demographics

Panic disorder has a lifetime prevalence estimated at approximately 1.7% globally (ranging from 0.4% to 3.8% across countries), based on cross-national epidemiological surveys, with 12-month prevalence typically around 1.0% in adult populations (data from pre-2020 surveys). In the United States, for instance, the lifetime prevalence is approximately 4.7%, while the past-year rate stands at 2.7% (based on 2001-2003 data). These figures highlight the disorder's relatively common occurrence among anxiety conditions, though it remains less prevalent than generalized anxiety disorder or specific phobias. Updated epidemiological data specific to panic disorder post-2020 remains limited. Demographically, panic disorder exhibits a pronounced disparity, with women affected at roughly twice the rate of men (a 2:1 female-to-male ratio). The peak age of onset occurs between 20 and 24 years, though cases can emerge across adulthood, and prevalence is higher in urban settings compared to rural areas, potentially due to environmental stressors like . Geographically, prevalence varies significantly, with higher rates reported in Western countries—such as 4.7% lifetime prevalence in the —compared to lower figures of 1-2% in many Asian populations. Socioeconomic factors also play a role, as the disorder is associated with lower income and education levels, which may exacerbate vulnerability through and limited access to resources. As of , post-pandemic analyses indicate a sustained increase in anxiety disorders, with global prevalence rising by up to 25% during the period and lingering elevations in affected subgroups.

Sociocultural influences

Cultural variations significantly influence the manifestation of panic disorder, with non- cultures often emphasizing symptoms over psychological interpretations predominant in contexts. For instance, in Latino communities, ataque de nervios represents a characterized by episodes of intense emotional distress, including uncontrollable screaming, trembling, and fainting, which overlap with but are distinct from classic panic attacks due to their ties to interpersonal stressors and family conflicts rather than isolated autonomic arousal. further reveal differences in symptom endorsement, such as higher reports of and paresthesias in and Asian groups compared to Caucasians, reflecting culturally shaped interpretations of bodily sensations as illness rather than transient anxiety. These presentations can lead to misdiagnosis or delayed recognition when applying diagnostic criteria, underscoring the need for culturally sensitive assessments. Stigma surrounding mental health poses substantial barriers to recognition and reporting of panic disorder, particularly in collectivist societies where and amplify underreporting. In Asian cultures, mental illnesses like anxiety disorders are often viewed as personal weaknesses that tarnish familial reputation, leading individuals to attribute symptoms to physical ailments or causes to avoid social ostracism. This cultural results in lower help-seeking behaviors, with studies showing that are less likely to disclose anxiety symptoms due to fears of being labeled "crazy" or burdening the community. Such barriers perpetuate untreated cases, exacerbating the disorder's impact on daily functioning. Access to treatment for panic disorder is disproportionately limited in low-income regions and influenced by gender biases, contributing to inequities in management. Low socioeconomic status correlates with reduced treatment utilization due to financial constraints, lack of insurance, and geographic barriers, as evidenced by studies of low-income African American women who face isolation and inadequate care for panic symptoms. Gender disparities manifest in higher diagnosis rates among women, who are over twice as likely to receive a panic disorder diagnosis than men, potentially due to greater symptom reporting and clinician biases toward recognizing anxiety in females. These factors result in lower treatment rates overall in underserved populations, hindering effective intervention. Immigration introduces acculturative that heightens vulnerability to among migrants, as the pressures of adapting to new cultural norms, language barriers, and trigger or intensify anxiety symptoms. Research indicates that acculturative serves as a for anxiety disorders, including attacks, by increasing physiological and cognitive misinterpretations of bodily sensations in immigrant populations. For example, immigrants experiencing cultural conflicts report elevated psychological distress, which manifests as heightened panic-like episodes linked to feelings of . This often compounds existing vulnerabilities, leading to poorer outcomes without targeted support. As of 2025, platforms play a dual role in panic disorder, potentially amplifying symptoms through exposure to anxiety-provoking content while also normalizing discussions that encourage help-seeking. Excessive use has been associated with heightened anxiety levels, including panic symptoms, via mechanisms like , , and constant comparison, particularly among adolescents and young adults. Recent surveys highlight that nearly half of teens perceive 's impact on peers as mostly negative for , correlating with increased reports of anxiety disorders. Conversely, online communities can foster awareness and reduce isolation, though unregulated content risks symptom escalation without professional guidance.

Special populations

Children and adolescents

Panic disorder in children and adolescents manifests differently from adults, with a lifetime of approximately 2.3% in U.S. adolescents aged 13-18 according to national surveys, though rates are lower (around 0.5%) in younger children. Triggers are frequently tied to settings, such as academic demands or interactions, which can precipitate unexpected panic attacks. Symptoms often emphasize complaints over psychological ones, including stomachaches, , or rapid heartbeat, leading children to describe attacks as physical illnesses rather than fear-based episodes. Additionally, there is notable overlap with , where fears of being away from caregivers may trigger or mimic panic symptoms. Diagnosing panic disorder in this population presents challenges, as intense fears can resemble normal developmental anxieties or other conditions like or gastrointestinal issues, often resulting in multiple medical evaluations before . Clinicians must distinguish recurrent, unprovoked attacks with persistent worry from transient stressors, adapting adult criteria to account for age-related expressions. Child-adapted tools, such as the Spence Children's Anxiety Scale (SCAS), aid in evaluation by measuring symptoms across domains including /agoraphobia and separation anxiety through self- and parent-reports. Treatment typically begins with modified (), tailored for youth with age-appropriate techniques like exposure exercises and family involvement to address parental of avoidance behaviors. Selective serotonin reuptake inhibitors (SSRIs), such as sertraline (FDA-approved for obsessive-compulsive disorder in children aged 6 and older), are effective pharmacological options used off-label for panic disorder and other anxiety disorders, often in combination with for enhanced outcomes. Recent 2025 research highlights rising rates of anxiety disorders among adolescents, attributed in part to excessive and heightened academic pressures, which exacerbate vulnerability through disrupted sleep and ; these trends may contribute to increased panic disorder cases. These trends underscore the need for early intervention in school-based settings to mitigate long-term impacts.

Older adults

Panic disorder is less prevalent among older adults compared to younger populations, with current prevalence rates estimated at approximately 1% to 2% in individuals aged 65 and older. Late-onset cases, emerging after age 60, are rare, as the disorder typically begins earlier in life. Underdiagnosis is common in this group, often because symptoms are mistakenly attributed to normal aging processes or conditions rather than a psychiatric disorder. In older adults, panic attacks frequently manifest with prominent cardiovascular symptoms, such as , , and , which can closely mimic cardiac events. This presentation heightens the risk of medical misdiagnosis, leading to unnecessary cardiac evaluations and delays in appropriate interventions. Comorbid chronic illnesses, particularly cardiovascular diseases like heart disease, serve as significant risk factors that can exacerbate panic attacks in the elderly. These conditions not only increase the frequency and intensity of episodes but also complicate symptom differentiation from physical ailments. Treatment approaches for panic disorder in older adults prioritize selective serotonin reuptake inhibitors (SSRIs) as first-line pharmacological options due to their efficacy and favorable safety profile in this population. Benzodiazepines, while effective for acute relief, are generally avoided or used cautiously because of their association with increased fall risk and in the elderly. remains a cornerstone , often adapted for age-related cognitive changes through extended session lengths, visual aids, and emphasis on explicit behavioral learning to enhance comprehension and retention. As of 2025, advancements in have notably improved access to care for geriatric patients with panic disorder, offering convenient delivery of and monitoring while addressing mobility and transportation barriers common in older age.

References

  1. [1]
    Panic Disorder - National Institute of Mental Health (NIMH)
    Panic Disorder is an anxiety disorder characterized by unexpected and repeated episodes of intense fear accompanied by physical symptoms.
  2. [2]
    Panic Disorder - StatPearls - NCBI Bookshelf - NIH
    Aug 6, 2023 · Panic disorder is characterized by recurrent, unexpected panic attacks. Panic attacks are defined by the Diagnostic and Statistical Manual of Mental Health ...
  3. [3]
    Panic disorder: History and epidemiology - PubMed
    The lifetime prevalence of DSM-III panic disorder and repeated panic attacks, defined as the average of individual estimates from six studies, are 2.7% and 7.1% ...<|separator|>
  4. [4]
    Panic attacks and panic disorder - Symptoms and causes
    May 4, 2018 · A panic attack is a sudden episode of intense fear that triggers severe physical reactions when there is no real danger or apparent cause.
  5. [5]
    Panic Disorder: What You Need to Know
    People with panic disorder have frequent and unexpected panic attacks. These attacks are characterized by a sudden wave of fear or discomfort or a sense of ...What is panic disorder? · What are the signs and... · How is panic disorder treated?
  6. [6]
    Pharmacological management of panic disorder - PMC - NIH
    Therefore, all the available guidelines recommend an SSRI compound as a first choice drug for the treatment of PD, given the beneficial side-effect profile of ...
  7. [7]
    Panic Attacks and Panic Disorder - Merck Manuals
    A panic attack is the sudden onset of a discrete, brief period of intense discomfort, anxiety, or fear accompanied by somatic and/or cognitive symptoms.
  8. [8]
    Panic Attacks & Panic Disorder: Causes, Symptoms & Treatment
    Medical or mental health providers can diagnose panic disorder based on criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Your ...
  9. [9]
    The Symptom Structure of Panic Disorder - PubMed
    Cluster analysis revealed three panic symptom clusters: cluster A (dyspnea, choking, sweating, nausea, flushes/chills); cluster B (dizziness, palpitations, ...
  10. [10]
    Panic disorder - PMC - PubMed Central - NIH
    This leads to hypervigilance about bodily sensations, increased arousal of the sympathetic nervous system, more physical sensations, and heightened anxiety ...
  11. [11]
    The Neurobiology of Anxiety Disorders: Brain Imaging, Genetics ...
    Mood and anxiety disorders are characterized by a variety of neuroendocrine, neurotransmitter, and neuroanatomical disruptions.
  12. [12]
    The Genetic Basis of Panic Disorder - PMC - PubMed Central - NIH
    Increasing evidence suggests genes underlying panic disorder overlap, transcending current diagnostic boundaries. In addition, an anxious temperament and ...Association Studies · Other Candidate Systems · Table 2
  13. [13]
    Genetic Biomarkers of Panic Disorder: A Systematic Review - PMC
    Nov 4, 2020 · Genes COMT and SLC6A4 may be considered the most promising for PD diagnostic to date. (4) Conclusions: This review illustrates current progress ...
  14. [14]
    α6-Containing GABAA Receptors: Functional Roles and Therapeutic ...
    Genetic studies in humans suggest an association of the human GABAA receptor α6 subunit gene with stress-associated disorders. Animal studies support this ...
  15. [15]
    HPA axis activity in patients with panic disorder - PubMed - NIH
    Patients with panic disorder had elevated overnight cortisol levels, which correlated with sleep disruption. ACTH and cortisol levels were higher in a challenge ...
  16. [16]
    [PDF] cortisol as an indicator of hypothalmic-pitituary-adrenal axis ...
    Data of HPA axis disturbance in panic disorder are inconsistent. In panic disorder HPA axis hyperactivity has been observed with elevated cortisol levels.
  17. [17]
    On the significance of cholecystokinin receptors in panic disorder
    This hypothesis is based on the results of animal electrophysiological studies, animal models of anxiety and on challenge test using CCK fragments in humans.
  18. [18]
    Mechanisms of estradiol in fear circuitry: implications for sex ... - Nature
    Aug 5, 2014 · The overwhelming prevalence of fear-related disorders in women suggests that there may be intrinsic sex differences in fear circuitry.
  19. [19]
    A cognitive approach to panic - PubMed
    A cognitive approach to panic. Behav Res Ther. 1986;24(4):461-70. doi: 10.1016/0005-7967(86)90011-2. Author. D M Clark.
  20. [20]
    Panic disorder: A product of classical conditioning - ScienceDirect.com
    Panic disorder is the result of contiguous stimuli, especially endogenous stimuli, being conditioned to the elicited anxiety.
  21. [21]
    Life events preceding the onset of panic disorder - PubMed
    The life events experienced in the 12 months prior to the first panic attack were studied in 23 patients with a DSM-III diagnosis of panic disorder as well ...Missing: percentage | Show results with:percentage
  22. [22]
    The Neurobiology of Panic: A Chronic Stress Disorder - PMC
    In this review, recent evidence for a neurobiological basis of panic disorder is reviewed with particular attention to risk factors such as genetic ...
  23. [23]
    Effects of caffeine on anxiety and panic attacks in patients ... - PubMed
    Dec 2, 2021 · The results confirm that caffeine at doses roughly equivalent to 5 cups of coffee induces panic attacks in a large proportion of PD patients.
  24. [24]
    Smoking Increases the Risk of Panic: Findings From a Prospective ...
    In the prospective analyses, we found increased risk for new onset of panic attacks with prior regular smoking (OR, 2.9; 95% confidence interval [CI], 1.0-8.4) ...
  25. [25]
    Panic Disorder After the End of Chronic Alcohol Abuse - NIH
    Panic attacks may be related to drinking aimed principally at reducing anxiety states and aversive bodily sensations. Yet such negative-affect–reduction ...Missing: sedative | Show results with:sedative
  26. [26]
    Treatment of cocaine-induced panic disorder - PubMed - NIH
    The authors describe 10 patients who developed panic attacks only after substantial cocaine use. The timing of the onset of symptoms, ie, after 1-6 years of ...Missing: precipitate | Show results with:precipitate<|control11|><|separator|>
  27. [27]
    The Parental Overprotection Scale: Associations with child and ...
    Parental overprotection has commonly been implicated in the development and maintenance of childhood anxiety disorders. Overprotection has been assessed ...Missing: adversity | Show results with:adversity
  28. [28]
    Separation Anxiety and Actual Separation Experiences during ...
    ... Childhood SAD has been identified as a possible gateway to both physical and psychiatric problems such as panic disorders in adolescence and early adulthood ...<|separator|>
  29. [29]
    Cities and Mental Health - PMC - NIH
    Studies on anxiety disorders (including posttraumatic stress disorder, distress, anger, and paranoia) found higher rates in urban versus rural areas in several ...<|separator|>
  30. [30]
    Psychological distress is more common in some occupations and ...
    Mar 31, 2023 · Workers in high risk occupations had 20% higher adjusted odds of developing distress than those in low risk occupations.
  31. [31]
    Clinical features and genetic mechanisms of anxiety, fear ... - Nature
    Aug 19, 2025 · Anxiety and fear are regulated by distinct but interacting neurobiological mechanisms, with the amygdala central to fear processing and the ...
  32. [32]
    The functional and structural alterations in brain regions related to ...
    Abnormal functional connectivity (FC) within the fear network model (FNM) has been identified in panic disorder (PD) patients, but the specific local ...
  33. [33]
    Resting-state functional connectivity in anxiety disorders - Nature
    Oct 4, 2024 · Task-based fMRI studies have shown increased activation in anxiety-related areas, such as the bilateral insula and medial prefrontal cortex [10] ...
  34. [34]
    Neurochemical and genetic factors in panic disorder: a systematic ...
    Jul 18, 2024 · The review reveals patterns of altered expression in various biological systems, including neurotransmission, the Hypothalamic-Pituitary-Adrenal ...
  35. [35]
    The role of the locus coeruleus in the generation of pathological ...
    This review aims to synthesise a large pre-clinical and clinical literature related to a hypothesised role of the locus coeruleus norepinephrine system in ...
  36. [36]
    Abnormal resting-state functional connectivity in panic disorder
    May 1, 2025 · Research paper. Abnormal resting-state functional connectivity in panic disorder: An exploratory whole-brain MRI study.
  37. [37]
    Anxiety Modulation by Cannabinoids-The Role of Stress Responses ...
    Oct 30, 2023 · Endocannabinoids were implicated in a variety of pathological conditions including anxiety and are considered promising new targets for anxiolytic drug ...
  38. [38]
    The Amygdala Is a Chemosensor that Detects Carbon Dioxide and ...
    Nov 25, 2009 · We found that inhaled CO2 reduced brain pH and evoked fear behavior in mice. Eliminating or inhibiting ASIC1a markedly impaired this activity, ...
  39. [39]
    The role of acid-sensitive ion channels in panic disorder
    Sep 7, 2018 · Evidence indicates that ASIC1a channels located in the amygdala detect a reduced pH arising from increased CO2 or from direct injection of acid, ...
  40. [40]
    Can Interoception Improve the Pragmatic Search for Biomarkers in ...
    Interoception refers to the process of how the brain senses and integrates signals originating from inside the body, providing a moment by moment mapping of the ...<|control11|><|separator|>
  41. [41]
    Interoceptive sensitivity in anxiety and anxiety disorders - PubMed
    Interoceptive sensitivity, particularly regarding heartbeat, has been suggested to play a pivotal role in the pathogenesis of anxiety and anxiety disorders.
  42. [42]
    The roles of interoceptive sensitivity and ... - PubMed Central - NIH
    Apr 8, 2015 · Background. Interoception (the ability to perceive bodily sensations) [1] has been proposed as a risk factor for panic attacks [1,2].
  43. [43]
    Interoception, conditioning, and fear: The panic threesome - PubMed
    The present article aims to illustrate and review evidence on how associative learning involving interoceptive stimuli (interoceptive conditioning) can lead ...
  44. [44]
    Interoceptive accuracy and panic - PubMed
    Infrequent panickers were more accurate in the perception of their heartbeats than nonanxious participants. Changes in physiological arousal were not associated ...
  45. [45]
    Can you feel the beat? Interoceptive awareness is an interactive ...
    In panic disorder some studies find superior heartbeat perception (e.g. Ehlers & Breuer, 1992; Zoellner & Craske, 1999), but there have been notable failures to ...
  46. [46]
    Interoceptive dimensions across cardiac and respiratory axes - PMC
    We demonstrate a dissociation between cardiac and respiratory measures of interoceptive accuracy (ie task performance), yet a positive relationship between ...
  47. [47]
    Reactivity to interoceptive cues in nocturnal panic - PubMed
    These findings are consistent with the notion that nocturnal panickers are fearful of states involving a diminution of conscious awareness or vigilance.
  48. [48]
    Personalized virtual reality exposure for panic disorder and ...
    Personalized VR exposure elicits stronger anxiogenic effects in patients with panic disorder and agoraphobia as suggested by self-report and neurophysiological ...
  49. [49]
    Electroencephalogram Changes After Virtual Reality-Based ...
    Jun 11, 2025 · This study indicated that VR-based CBT may alleviate panic symptoms and enhance cognitive functions, particularly executive control.
  50. [50]
    [Box], EXHIBIT 4.9. Diagnostic Criteria for Panic Disorder - NCBI
    1. Palpitations, pounding heart, or accelerated heart rate · 2. Sweating · 3. Trembling or shaking · 4. Sensations of shortness of breath or smothering · 5.
  51. [51]
    Panic Disorder Differential Diagnoses - Medscape Reference
    Jun 25, 2024 · Angina and myocardial infarction (eg, dyspnea, chest pain, palpitations, diaphoresis) · Cardiac dysrhythmias (eg, palpitations, dyspnea, syncope).
  52. [52]
    Biobehavioral approach to distinguishing panic symptoms ... - Frontiers
    May 7, 2024 · This narrative review examines six common somatic symptoms of panic attacks (non-cardiac chest pain, palpitations, dyspnea, dizziness, abdominal distress, and ...<|separator|>
  53. [53]
    Medical mimics: Differential diagnostic considerations for psychiatric ...
    The diagnostic schema for ruling out medical mimics requires critical thinking, a multifactorial approach, clinical diligence, exclusion of infectious disease( ...
  54. [54]
    Anxiety Disorders Differential Diagnoses - Medscape Reference
    Mar 19, 2024 · Anxiety also can be observed as part of a drug withdrawal or drug intoxication effect. Other important causes in the differential include ...
  55. [55]
    Anxiety Disorders with Comorbid Substance Use Disorders - NIH
    In this article, co-occurring SUDs and anxiety disorders will be briefly reviewed, including prevalence, diagnostic issues, and treatment options.
  56. [56]
    Substance/Medication-Induced Anxiety Disorder - PsychDB
    Feb 3, 2022 · Substance/medication-induced anxiety disorder is diagnosed after an individual uses a substance (eg, a drug of abuse, a medication, or a toxin exposure)
  57. [57]
    Nocturnal Panic Attack: Anxiety, Panic Disorder & Night Terrors
    A person experiencing a night terror has symptoms like those of a nocturnal panic attack. One key difference is awareness. People experiencing night terrors are ...Missing: differential | Show results with:differential
  58. [58]
    The overlap between anxiety, depression, and obsessive ...
    DSM-5 provides a somewhat divisive starting point for looking at the overlap between major depression, anxiety disorder, and obsessive-compulsive disorder (OCD) ...
  59. [59]
    a comparison with unipolar depression, panic disorder, and normal ...
    Neuropsychological deficits were observed in patients with OCD that were not observed in matched patients with panic disorder or unipolar depression.
  60. [60]
    Long COVID: Lasting effects of COVID-19 - Mayo Clinic
    Aug 23, 2024 · What are the most common symptoms of long COVID? · Heart disease. · Mood disorders. · Anxiety. · Stroke or blood clots. · Postural orthostatic ...
  61. [61]
    Neuropsychiatric Manifestations of Long COVID-19 - PubMed Central
    Many neurological manifestations of L-C19 overlap with psychiatric symptoms, such as anxiety and depression, which are often seen alongside cognitive ...
  62. [62]
    Practice Guideline for the Treatment of Patients With Panic Disorder
    Group therapy. Clinical experience suggests that possible benefits of a group format for treating panic disorder include 1) decreas- ing shame and stigma by ...Missing: psychotherapy | Show results with:psychotherapy
  63. [63]
    The Efficacy of Cognitive Behavioral Therapy: A Review of Meta ...
    Oct 1, 2012 · The goal of this review was to provide a comprehensive survey of meta-analyses examining the efficacy of CBT. We identified 269 meta-analytic ...
  64. [64]
    Cognitive-behavioral therapy for panic: effectiveness and limitations
    Controlled studies have demonstrated that cognitive-behavioral therapy is superior to other treatments for panic--85% of patients are panic-free at ...
  65. [65]
    Cognitive Behavioral Therapy for Anxiety Disorders - PubMed
    CBT includes core components that are relevant across anxiety disorders, including psychoeducation, cognitive restructuring, exposure therapy, and relapse ...
  66. [66]
    Generalised anxiety disorder and panic disorder in adults ... - NICE
    Jan 26, 2011 · This guideline covers the care and treatment of people aged 18 and over with generalised anxiety disorder (chronic anxiety) or panic disorder (with or without ...Management · Appendix: Assessing... · Anxiety disorders · Tools and resources
  67. [67]
    Interoceptive hypersensitivity and interoceptive exposure in patients ...
    Aug 16, 2006 · Interoceptive exposure has been validated as an effective component of cognitive behavioral therapy (CBT) for the treatment of panic disorder.
  68. [68]
    Interoceptive hypersensitivity and interoceptive exposure in patients ...
    Aug 16, 2006 · In a case study, interoceptive exposure alone was found to be effective in reducing panic, panic-related fears, and general anxiety [8]. The ...
  69. [69]
    Brief Acceptance and Commitment Therapy and Exposure for Panic ...
    Acceptance and Commitment Therapy (ACT) involves creating an open, nonjudgmental stance toward whatever thoughts, feelings, and bodily sensations arise in a ...
  70. [70]
    Panic-Focused Psychodynamic Psychotherapy | Psychiatric Times
    In a recent randomized controlled trial, 18 PFPP demonstrated efficacy for panic disorder in comparison to a less-active psychotherapy called applied relaxation ...
  71. [71]
    A Meta-Analytic Review of Clinical Components to Maximize Efficacy
    Mar 6, 2025 · This review aimed to identify the efficacy of digital cognitive behavioral therapy for panic disorder and agoraphobia, and examine whether applying relevant ...
  72. [72]
    Panic Disorder Medication - Medscape Reference
    Jun 25, 2024 · Medication Summary. First-line pharmacologic therapies for panic disorder include selective serotonin reuptake inhibitors (SSRIs), serotonin ...Missing: side | Show results with:side
  73. [73]
    Pharmacotherapy of Anxiety Disorders: Current and Emerging ...
    The recommended duration of treatment can vary but may be as short as 3–6 months, or up to 1–2 years or even longer. Although there may be concern about ...
  74. [74]
    Pharmacologic Management of Acute and Chronic Panic Disorder
    Nov 16, 2015 · Though all four classes of medication have displayed approximately equivalent efficacy in studies, SSRIs ... Pharmacological management of panic ...
  75. [75]
    Selective Serotonin Reuptake Inhibitors and Adverse Effects
    Aug 5, 2021 · This does not increase their rate of adverse effects, but care should be taken when prescribing these drugs to a patient with impaired drug ...
  76. [76]
    Panic attacks and panic disorder - Diagnosis and treatment
    May 4, 2018 · These medications are not a good choice if you've had problems with alcohol or drug use. They can also interact with other drugs, causing ...Missing: efficacy | Show results with:efficacy
  77. [77]
    Benzodiazepines for Panic Disorder in Adults - AAFP
    Apr 1, 2020 · The authors acknowledge the risk of dependency and withdrawal and support the current recommendations to avoid the use of benzodiazepines as ...
  78. [78]
    Pharmacological management of panic disorder | BJPsych Advances
    Aug 8, 2025 · Drug classes. In terms of efficacy based on response outcomes (Table 1), all medication classes studied (SSRIs, SNRIs, TCAs, MAOIs, BDZs) ...Treatments For Panic... · Benzodiazepines · Individual Drugs<|control11|><|separator|>
  79. [79]
    The effect of sertraline with or without propranolol on panic attacks in ...
    Jul 4, 2025 · Based on the results of this trial, using propranolol alongside sertraline reduces the severity of panic attacks.
  80. [80]
    Panic Disorder: Effective Treatment Options - AAFP
    May 15, 1998 · Tricyclic Antidepressants​​ Imipramine (Tofranil) is the medication for panic disorder that has been most thoroughly studied, with at least 10 ...
  81. [81]
    Evidence-based pharmacotherapy of panic disorder: an update
    Another disadvantage is that these drugs may lead to benzodiazepine dependence. Moreover, benzodiazepines are generally thought ineffective with regard to ...
  82. [82]
    A long, strange trip: Ketamine treatment in psychiatry - PMC
    Oct 27, 2025 · Since then, ketamine has been tested against major and treatment-resistant depression in at least 25 research studies (see Price et al., 2022).
  83. [83]
    Ketamine Treatment For Refractory Anxiety: A Systematic Review
    Feb 20, 2025 · Several studies underscore ketamine's promise in treating refractory anxiety disorders. These studies support its rapid onset and significant ...Ketamine Treatment For... · Refractory Anxiety... · Ketamine's History And...Missing: derivatives panic<|separator|>
  84. [84]
    Healthy Lifestyle Interventions Augmenting Psychotherapy in ... - NIH
    This article gives examples of how to integrate evidence-based, healthy lifestyle interventions into the overall treatment of common psychiatric conditions.
  85. [85]
    Exploring exercise as an avenue for the treatment of anxiety disorders
    found that individuals with panic disorder who engaged in 30 min of aerobic exercise (70% of VO2 max) were less likely to have a panic attack in response to a ...
  86. [86]
    Effects of Exercise and Physical Activity on Anxiety - PMC
    Adults who engage in regular physical activity experience fewer depressive and anxiety symptoms, thus supporting the notion that exercise offers a protective ...
  87. [87]
    The exercise effect - American Psychological Association
    Dec 1, 2011 · The findings suggest that physical exercise could help to ward off panic attacks. "Activity may be especially important for people at risk of ...Missing: 20-30% endorphins
  88. [88]
    Caffeine intake and anxiety: a meta-analysis - PMC - PubMed Central
    Feb 1, 2024 · The results confirm that caffeine intake is associated with an elevated risk of anxiety in healthy individuals without psychiatric disorders.
  89. [89]
    Nocturnal Panic Attack: Causes and Tips for Relief | Sleep Foundation
    Jul 16, 2025 · Nocturnal panic attacks involve a sleeper clearly waking up. In contrast, someone experiencing a night terror is not fully awake or ...Missing: differential | Show results with:differential
  90. [90]
    The Role of Sleep in Panic Disorder - Dr Elaine Ryan
    May 20, 2024 · Improving sleep hygiene is crucial for individuals with panic disorder to help break the cycle of sleep anxiety and panic attacks. Here are some ...
  91. [91]
    10 Free Mental Health Apps to Support Your Well-Being
    Aug 4, 2023 · Mindshift is an app developed by Anxiety Canada to help individuals cope with worry, panic, social anxiety, and more. It contains simple, ...
  92. [92]
    Is the Course of Panic Disorder the Same in Women and Men?
    We found 1-year remission rates of 37% for panic disorder and 17% for panic disorder with agoraphobia (17), but among the patients who attained remission, ...
  93. [93]
    The long-term course of panic disorder—an 11 year follow-up
    Over a period of 11 years there is a good chance of recovery from panic attacks and disabilities, and full remission is also possible.
  94. [94]
    Full article: Is it possible to prevent relapse in panic disorder?
    Treatment-as-usual studies lasting from 3 to 8 years showed cumulative relapse rates ranging from 50% to 89% [Citation6]. In a 6-year follow-up study, Freire et ...
  95. [95]
    Increased Probability of Remaining in Remission from Panic ...
    Of patients who received integrated treatment (n = 21), only 3 (14.3%) relapsed. The estimated mean survival time was 65 months (95% CI 44–86). Treatment was ...
  96. [96]
    Functional Impairment in Patients with Panic Disorder - PMC - NIH
    Moreover, defined as fear of anxiety symptoms, AS differs from phobia or agoraphobia in that it is more motivational and logical because individuals with high ...Characteristics Of Clinical... · Table 5 · Discussion
  97. [97]
    Anxiety disorders - The Lancet
    Among patients with only one anxiety disorder, 2 year remission rates were around 70% for panic disorder without agoraphobia and generalised anxiety disorder, ...Anxiety Disorders · Clinical Management · Psychotherapy<|control11|><|separator|>
  98. [98]
    The bergen 4-day treatment for panic disorder: a longer-term follow-up
    Feb 7, 2025 · Cognitive behavioral therapy (CBT), in addition to pharmacological treatment by selective serotonin reuptake inhibitors, is considered the ...
  99. [99]
    Lifetime Panic-Depression Comorbidity in the National Comorbidity ...
    Unlike clinical studies, we deal with lifetime comorbidity and focus on predictive priorities between the first onsets of these disorders to shed light on the ...Missing: prioritization | Show results with:prioritization
  100. [100]
    7.3: Anxiety Disorders - Comorbidity - Social Sci LibreTexts
    Oct 6, 2022 · Panic disorder rarely occurs in isolation, as 80% of individuals report symptoms of other anxiety disorders, major depressive disorder, bipolar ...<|control11|><|separator|>
  101. [101]
    Anxiety Disorders With Comorbid Substance Abuse | Psychiatric Times
    Sep 7, 2011 · In anxiety disorder, there is a 33% to 45% 12-month prevalence rate for a comorbid substance use disorder (SUD).
  102. [102]
    Panic disorder with and without agoraphobia: comorbidity within a ...
    Dec 1, 2005 · A total of 40.6% of the patients developed agoraphobia within 24 weeks of the onset of panic disorder, and onset age and sex differences had no ...Abstract · INTRODUCTION · MATERIALS AND METHODS · RESULTS
  103. [103]
    Anxiety, a significant risk factor for coronary artery disease
    Jun 14, 2024 · Anxiety symptoms, particularly panic disorder, are independently and significantly associated with an increased overall risk of developing CAD over a 10-year ...
  104. [104]
    Panic Disorder, Comorbidity, and Suicide - Attempts - JAMA Network
    elevated risk for suicide attempts: for panic disorder compared with no disorder, odds ratio was 5.4 for uncomplicated and 22.8 for comor¬ ... plus major ...<|separator|>
  105. [105]
    The Association Between Anxiety and Autoimmune Diseases
    Sep 18, 2023 · The findings revealed a significant association, with individuals experiencing anxiety being 1.28 times more likely to develop autoimmune diseases compared to ...
  106. [106]
    Long COVID and anxiety: Connection, research, and more
    Jul 24, 2024 · Research suggests that there is a link between long COVID and mental health conditions, such as anxiety. A person may also be more likely to experience panic ...Long COVID and anxiety · Panic attacks · Effects on the brain · Treatment
  107. [107]
    Cross-national Epidemiology of Panic Disorder and Panic Attacks in ...
    Lifetime prevalence of PAs was 13.2% (s.e. 0.1%). Among persons that ever had a PA, the majority had recurrent PAs (66.5%; s.e. 0.5%), while only 12.8% ...
  108. [108]
    Gender Differences in Panic Disorder - Psychiatric Times
    Panic disorder is 2.5 times more prevalent among women than men. In addition, the gender difference appears to increase according to age.
  109. [109]
    Panic Disorder - camhi.gr
    Gender comparative data for Panic Disorder suggests that females are more likely to be diagnosed than males at a rate of 2:1. Peak age of onset. The peak age of ...
  110. [110]
    Urban/rural differences in the prevalence of anxiety disorders.
    Results indicate that 2 anxiety disorders—agoraphobia and panic disorder—were significantly related to place of residence, with higher prevalence among urban ...
  111. [111]
    A Cross-Ethnic Comparison of Lifetime Prevalence Rates of Anxiety ...
    The purpose of the present study was to examine differences in the lifetime prevalence rates of anxiety disorders between ethnic and racial minority groups in ...
  112. [112]
    ASSOCIATIONS BETWEEN HOUSEHOLD AND NEIGHBORHOOD ...
    The impact of household socioeconomic status (SES) (e.g. family income, education, and poverty status) on internalizing disorders such as anxiety ...
  113. [113]
    The Impact of Socioeconomic Factors on Mental Health
    Jul 18, 2025 · Individuals from lower social classes often experience chronic anxiety due to persistent financial instability, unsafe living conditions, or job ...
  114. [114]
    COVID-19 pandemic triggers 25% increase in prevalence of anxiety ...
    Mar 2, 2022 · In the first year of the COVID-19 pandemic, global prevalence of anxiety and depression increased by a massive 25%, according to a scientific brief released by ...Missing: panic | Show results with:panic
  115. [115]
    Post-pandemic changes in anxiety and depression symptom ...
    Aug 16, 2025 · The COVID-19 pandemic has significantly affected the mental health of young adults, particularly those facing socioeconomic hardship.
  116. [116]
    Ataques de nervios: culturally bound and distinct from panic attacks?
    Included among the syndromes are ataques de nervios (ADN), which are reported to be bound to the Hispanic culture and closely resemble panic attacks. However, ...
  117. [117]
    Ataque de nervios and panic disorder | American Journal of Psychiatry
    Ataque de nervios overlaps with panic disorder but is a more inclusive construct. Further study of its interrelation with axis I disorders is needed.
  118. [118]
    Cross-cultural variations in the prevalence and ... - PubMed
    This article indicates that certain anxiety disorders (e.g., generalized anxiety disorder and panic disorder) may vary greatly in rate across cultural groups.
  119. [119]
    Cross-cultural variations in the prevalence and presentation of ...
    Jan 9, 2014 · A difference in catastrophic cognitions about anxiety symptoms across cultures is hypothesized to be a key aspect of cross-cultural variation in ...Prevalence · Phenomenology · Panic & Related Disorders
  120. [120]
    Cultural factors influencing the mental health of Asian Americans - NIH
    In manyAsian cultures, mental illness is stigmatizing; it reflects poorly on familylineage and can influence others' beliefs about the suitability of ...
  121. [121]
    Asian Americans - Psychiatry.org
    Stigma towards mental illnesses: Stigma surrounding mental illness may prevent some Asian Americans from admitting to symptoms of mental illness. They are also ...
  122. [122]
    Cross-Cultural Aspects of Anxiety Disorders - PMC - NIH
    Within the US, a mutli-cultural country, Asian Americans consistently endorse symptoms of anxiety disorders (social anxiety disorder, generalized anxiety ...
  123. [123]
    Lives in Isolation: Stories and Struggles of Low‐income African ...
    Peer‐support groups for low‐income African American women with panic disorder could address many of the identified access and treatment barriers.Missing: regions | Show results with:regions
  124. [124]
    Poverty and Response to Treatment Among Panic Disorder Patients ...
    Aug 1, 2006 · This analysis confirms prior findings that low-income psychiatric patients with depression and anxiety have more severe symptoms and functional ...
  125. [125]
    Gender differences in panic disorder: findings from the ... - PubMed
    Objective: Several epidemiological studies have demonstrated a higher prevalence of panic disorder in women than in men. This study explored whether the ...
  126. [126]
    Acculturative stress as a risk factor of depression and anxiety in the ...
    This study explores acculturative stress as a risk factor for depressive and anxiety disorders as well as their symptomatology.
  127. [127]
    The Role of Acculturative Stress on the Mental Health of Immigrant ...
    Acculturative stress was associated with symptoms of major depression, anxiety disorders and somatic complaints over time, and these mental health problems ...
  128. [128]
    Acculturative stress as a risk factor of depression and anxiety in the ...
    Feb 21, 2011 · Abstract. This study explores acculturative stress as a risk factor for depressive and anxiety disorders as well as their symptomatology.<|separator|>
  129. [129]
    Social Media and Mental Health: Benefits, Risks, and Opportunities ...
    1) Impact on symptoms Studies show increased exposure to harm, social isolation, depressive symptoms and bullying · 2) Facing hostile interactions ...
  130. [130]
    Teens, Social Media and Mental Health - Pew Research Center
    Apr 22, 2025 · Roughly half of teens (48%) say these sites have a mostly negative effect on people their age, up from 32% in 2022. But fewer (14%) think they ...
  131. [131]
    Panic disorder in children and adolescents - PubMed
    Although PD was thought to be rare in children and adolescents, the prevalence of PD in community samples ranges between 0.5% and 5.0, and in pediatric ...
  132. [132]
    Panic Disorder Factsheet (for Schools) | Nemours KidsHealth
    Students with anxiety disorders may have difficulty completing classwork and homework, which can cause panic attacks and possibly lead to panic disorder.
  133. [133]
    Panic Disorder In Children And Adolescents - AACAP
    Children and adolescents with panic disorder have unexpected and repeated times of intense fear or discomfort, along with other symptoms such as a racing ...
  134. [134]
    Childhood Separation Anxiety Disorder and Panic Disorder
    Sep 17, 2024 · The association between childhood separation anxiety disorder (CSAD) and panic disorder (PD) has been demonstrated, although some findings are contradictory.
  135. [135]
    Panic Disorder in Children and Adolescents - Pediatrics
    Symptoms of a panic attack involve a sudden surge of intense fear, accompanied by somatic symptoms (eg, palpitations, sweating, trembling, shortness of breath ...
  136. [136]
    SCAS CHILD - Overview - The Spence Children's Anxiety Scale
    The scale assesses six domains of anxiety including generalized anxiety, panic/agoraphobia, social phobia, separation anxiety, obsessive compulsive disorder ...
  137. [137]
    Anxiety Disorders in Children and Adolescents - AAFP
    Physical symptoms of anxiety disorders in children and adolescents manifest as autonomic nervous system activation, including diaphoresis, palpitations, chest ...
  138. [138]
    Cognitive Behavioral Therapy, Sertraline, or a Combination in ...
    Oct 30, 2008 · Both cognitive behavioral therapy and sertraline reduced the severity of anxiety in children with anxiety disorders; a combination of the two therapies had a ...
  139. [139]
    Pharmacotherapy for anxiety disorders in children and adolescents
    Multiple RCTs support the efficacy of SSRIs, both alone and in combination with therapy, for the treatment of anxiety disorders in children and adolescents.
  140. [140]
    Contributing Factors to the Rise in Adolescent Anxiety and ... - NIH
    Dec 30, 2024 · We provide a comprehensive overview of the factors contributing to the increased rates of adolescent anxiety, including academic pressures, social media ...
  141. [141]
    Screen time and emotional problems in kids: A vicious circle?
    Jun 9, 2025 · “We found that increased screen time can lead to emotional and behavioral problems, and kids with those problems often turn to screens to cope.”
  142. [142]
    Screen time exposure and academic performance, anxiety ... - PeerJ
    May 8, 2025 · Screen time exposure and academic performance, anxiety, and behavioral problems among school children. Research Article.
  143. [143]
    Panic disorder in older adults - Wiley Online Library
    Jul 7, 2010 · The current and lifetime prevalence rates of panic disorder were 1.17 and 3.72%, respectively. Multivariate analyses revealed that panic ...
  144. [144]
    Anxiety in Later Life | Focus - Psychiatry Online
    Apr 10, 2017 · Panic disorder (PD) occurs in less than 0.5% of older adults, and onset in late life is rare (12). Prevalence ranges vary, from 0.4% to 2.8%, ...
  145. [145]
    Diagnosis and management of panic disorder in older patients
    Abstract. Panic disorder occurs less frequently in the elderly than in younger adults and rarely starts for the first time in old age.<|separator|>
  146. [146]
    Seniors' anxiety: Underdiagnosed and undertreated
    Oct 1, 2023 · Although complaints about anxiety are common among older persons, late-life anxiety disorders have been underestimated.
  147. [147]
    Panic disorder and the heart: a cardiology perspective - ScienceDirect
    Chest pain and palpitations are the cardinal symptoms that may masquerade as a primary cardiovascular disorder yet represent a diagnosis of panic disorder.
  148. [148]
    Anxiety disorders and cardiovascular disease - PMC - NIH
    Anxiety disorders are associated with the onset and progression of cardiac disease, and in many instances have been linked to adverse cardiovascular outcomes, ...
  149. [149]
    Pharmacological Management of Anxiety Disorders in the Elderly
    Feb 10, 2017 · Antidepressants are considered first line treatment. Both SSRIs and SNRIs are efficacious and well-tolerated in the elderly.Missing: adaptations | Show results with:adaptations
  150. [150]
    Practical Geriatrics: Use of Benzodiazepines Among Elderly Patients
    Several studies showed evidence for increased risk of hip fracture and recurrent falls among elderly patients taking benzodiazepines.
  151. [151]
    Treating Panic Disorders in the Aging Population - Supportive Care
    Sep 15, 2025 · In fact, most cases of panic attacks in seniors are linked to an earlier onset of the disorder, with late-onset occurrences being quite rare.
  152. [152]
    COGNITIVE‐BEHAVIORAL THERAPY FOR PANIC DISORDER ...
    May 27, 2014 · The first RCT directly comparing younger and older adults confirmed the limited effectiveness for both antidepressants and CBT in older adults ...<|separator|>
  153. [153]
    Smart-Home Innovation for Older Adults' Mental Health - CDC
    Jul 17, 2025 · Traditionally, older adults turned to pharmacotherapy, psychotherapy, and family caregiving (5). In recent decades, telehealth increased access ...Missing: panic geriatric